Production (Stage)
Scinai Immunotherapeutics Ltd.
SCNI
$2.72
$0.031.12%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -6.50M | -4.17M | -6.50M |
| Total Depreciation and Amortization | -- | -- | 514.00K | 430.00K | 283.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -2.60M | 317.00K | 2.93M |
| Change in Net Operating Assets | -- | -- | -796.00K | -4.73M | -3.44M |
| Cash from Operations | -- | -- | -9.38M | -8.16M | -6.72M |
| Capital Expenditure | -- | -- | -637.00K | -403.00K | 29.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -637.00K | -403.00K | 29.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 1.09M | 1.09M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 1.09M | 1.09M | -140.00K |
| Foreign Exchange rate Adjustments | -- | -- | -272.00K | -258.00K | -704.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -9.21M | -7.73M | -7.40M |